Antagonist - PDFSEARCH.IO - Document Search Engine

Antagonist
Results: 956

#	Item
741	Microsoft Word - sample abstract.doc Add to Reading List Source URL: www.uni-regensburg.de Language: English - Date: 2014-05-28 10:01:28 Biochemistry Pharmacology Receptor antagonist 5-HT2A receptor Amides Piperazines Bifeprunox Signal transduction Biology Chemistry
742	Microsoft PowerPoint - SWVHConferenceLV-AmySmith.ppt [Compatibility Mode] Add to Reading List Source URL: health.nv.gov Language: English - Date: 2009-02-13 13:22:24 Pharmacology Miglitol Angiotensin II receptor antagonist Quinapril Fosinopril Metformin Monoamine oxidase inhibitor Serotonin reuptake inhibitor Beta blocker Chemistry Organic chemistry ACE inhibitors
743	Fall Prevention - Case Study 2 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2012-12-11 10:44:51 Health Anatomy Orthostatic hypotension Angiotensin II receptor antagonist Fall prevention Valsartan Dizziness Balance disorder Standing Medicine Hypotension Neurological disorders
744	Mini-Sentinel: FDA’s New Tool for Monitoring the Safety of FDAApproved Medical Products Melissa Robb Project Director, Sentinel Initiative Office of Medical Policy Center for Drug Evaluation and Research Add to Reading List Source URL: www.fda.gov Language: English Clinical research Research Pharmaceutical industry Therapeutics Angiotensin II receptor antagonist Approved drug Adverse Event Reporting System Research on Adverse Drug events And Reports Food and Drug Administration Pharmaceutical sciences Pharmacology
745	The Science of Sex and Gender in Human health – PK-PD applications or case studies Add to Reading List Source URL: www.fda.gov Language: English Pharmacy Drug discovery Heparins Sulfonamides Pharmacodynamics Pharmacokinetics Alosetron Dofetilide 5-HT3 antagonist Pharmaceutical sciences Pharmacology Chemistry
746	Atypical Antipsychotics and Pituitary Tumors: A Pharmacovigilance Study Ana Szarfman, M.D., Ph.D., Joseph M. Tonning, M.D., M.P.H., Jonathan G. Levine, Ph.D., and P. Murali Doraiswamy, M.D. Study Objective. To analyze th Add to Reading List Source URL: www.fda.gov Language: English Piperazines Organochlorides Alcohols Lactams Antipsychotic Dopamine antagonist Aripiprazole Quetiapine Haloperidol Chemistry Organic chemistry Atypical antipsychotics
747	Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist) Add to Reading List Source URL: www.fda.gov Language: English Drug rehabilitation Dosage forms Substance dependence Morphinans Buprenorphine Opioid dependence Drug Addiction Treatment Act Methadone Reckitt Benckiser Chemistry Pharmacology Medicine
748	Initial REMS Approved: March[removed]Most Recent Modification: July 2013 NDA[removed]VIVITROL® (naltrexone for extended-release injectable suspension) Opioid Antagonist Add to Reading List Source URL: www.fda.gov Language: English Morphinans Alcohols Euphoriants Phenols Ketones Naltrexone Buprenorphine Methadone Heroin Chemistry Medicine Organic chemistry
749	SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist) Add to Reading List Source URL: www.fda.gov Language: English Morphinans Drug rehabilitation Ketones Substance dependence Buprenorphine Naloxone Opioid dependence Drug Addiction Treatment Act Methadone Chemistry Organic chemistry Alcohols
750	N:ft NOV'segraAllegraDTC[removed]doc Add to Reading List Source URL: www.fda.gov Language: English Carboxylic acids Piperidines Ethers Piperazines Fexofenadine H1 antagonist Cetirizine Histamine antagonist Direct-to-consumer advertising Chemistry Organic chemistry Organochlorides

UPDATE